10 Recruiting Studies Using Duvelisib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Duvelisib
Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
📍 City of Hope Medical Center — Duarte, California
Recurrent Chronic Lymphocytic Leukemia
View Study & Checklist ➔Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
View Study & Checklist ➔Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
📍 Washington University School of Medicine — St Louis, Missouri
Non-hodgkin Lymphoma
View Study & Checklist ➔Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
📍 University of Miami- Sylvester Comprehensive Cancer Center — Miami, Florida
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides
📍 Johns Hopkins University — Baltimore, Maryland
Mycosis Fungoides
View Study & Checklist ➔A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
📍 Memorial Sloan Kettering Basking Ridge (LimitedProtocol Activities) — Basking Ridge, New Jersey
Anaplastic Lymphoma Kinase
View Study & Checklist ➔A Study of Ruxolitinib and Duvelisib in People With Lymphoma
📍 University of Miami (Data Collection Only) — Miami, Florida
T-cell Lymphomas
View Study & Checklist ➔Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
📍 City of Hope Medical Center — Duarte, California
Follicular Helper T-Cell Lymphoma
View Study & Checklist ➔Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
📍 David Geffen School of Medicine at the University of California at Los Angeles — Los Angeles, California
T-cell-prolymphocytic Leukemia
View Study & Checklist ➔Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Angioimmunoblastic T-cell Lymphoma
View Study & Checklist ➔